Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 4, 2017Journal of Biological ChemistryOpen Access

Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response

View Full Paper
Ask AI
Bookmark
Share

Authors

CZConggang ZhangCenter for Life SciencesZLZeyu LiuChinese Academy of SciencesEBEric BunkerNational Institute of Neurological Disorders and Stroke

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2017) studied this question.

synapsesocial.com/papers/6a71c0eaa7fbea1e44087f6dhttps://doi.org/10.1074/jbc.m117.783175
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Alterations of the Tumor Suppressor Gene Parkin in Non-Small Cell Lung Cancer2004 · 117 citations
  2. 2Mitochondria and Neuronal Survival2000 · 1,254 citations
  3. 3Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress2008 · 706 citations
  4. 4Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience2010 · 193 citations
  5. 5Parkin gene alterations in hepatocellular carcinoma2004 · 119 citations